{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T02:00:25Z","timestamp":1787796025086,"version":"build-2784847793"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T00:00:00Z","timestamp":1745884800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T00:00:00Z","timestamp":1745884800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Oncol."],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s13402-025-01059-4","type":"journal-article","created":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T08:31:54Z","timestamp":1745915514000},"page":"991-1003","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Postoperative continuous saline bladder irrigation reduces active urinary cancer cells: a prospective study in NMIBC"],"prefix":"10.1007","volume":"48","author":[{"given":"Qi","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhua","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gan","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanzhen","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peipei","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duo","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongzhe","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youyan","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingang","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shujun","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaitai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianzhong","family":"Shou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,29]]},"reference":[{"key":"1059_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"H. Sung, J. Ferlay, R.L. Siegel, M. Laversanne, I. Soerjomataram, A. Jemal, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 71, 209\u2013249 (2021)","journal-title":"CA Cancer J Clin"},{"key":"1059_CR2","doi-asserted-by":"publisher","first-page":"S34","DOI":"10.1038\/551S34a","volume":"551","author":"C. Berdik","year":"2017","unstructured":"C. Berdik, Unlocking bladder cancer. Nature 551, S34\u20135 (2017)","journal-title":"Nature"},{"key":"1059_CR3","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.eururo.2005.12.031","volume":"49","author":"R.J. Sylvester","year":"2006","unstructured":"R.J. Sylvester, et al., Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur Urol 49, 466\u2013477 (2006)","journal-title":"Eur Urol"},{"key":"1059_CR4","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1111\/bju.13599","volume":"119","author":"T. Onishi","year":"2017","unstructured":"T. Onishi, Y. Sugino, T. Shibahara, S. Masui, T. Yabana, T. Sasaki, Randomized controlled study of the efficacy and safety of continuous saline bladder irrigation after transurethral resection for the treatment of non-muscle-invasive bladder cancer. Bju International 119, 276\u2013282 (2017)","journal-title":"Bju International"},{"key":"1059_CR5","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1007\/s00345-019-02628-7","volume":"37","author":"Z. Zhou","year":"2019","unstructured":"Z. Zhou, S. Zhao, Y. Lu, J. Wu, Y. Li, Z. Gao, et al., Meta-analysis of efficacy and safety of continuous saline bladder irrigation compared with intravesical chemotherapy after transurethral resection of bladder tumors. World J. Urol. 37, 1075\u20131084 (2019)","journal-title":"World J. Urol."},{"key":"1059_CR6","doi-asserted-by":"publisher","first-page":"7872","DOI":"10.7150\/thno.44634","volume":"10","author":"C.K. Chen","year":"2020","unstructured":"C.K. Chen, J. Liao, M.S. Li, B.L. Khoo, Urine biopsy technologies: cancer and beyond. Theranostics 10, 7872\u20137888 (2020)","journal-title":"Theranostics"},{"key":"1059_CR7","doi-asserted-by":"crossref","unstructured":"A.B. Smith, B. Jaeger, L.C. Pinheiro, L.J. Edwards, H.-J. Tan, M.E. Nielsen, et al. Impact of bladder cancer on health-related quality of life. Bju International. 121, 549\u2013557 (2018)","DOI":"10.1111\/bju.14047"},{"key":"1059_CR8","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1111\/bju.15382","volume":"129","author":"T. Lebret","year":"2022","unstructured":"T. Lebret, G. Pignot, M. Colombel, L. Guy, X. Rebillard, L. Savareux, et al., Artificial intelligence to improve cytology performances in bladder carcinoma detection: results of the VisioCyt test. Bju International 129, 356\u2013363 (2022)","journal-title":"Bju International"},{"key":"1059_CR9","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1111\/j.1464-410X.2006.06036.x","volume":"97","author":"P.I. Karakiewicz","year":"2006","unstructured":"P.I. Karakiewicz, S. Benayoun, C. Zippe, G. L\u00fcdecke, H. Boman, M. Sanchez-Carbayo, et al., Institutional variability in the accuracy of urinary cytology for predicting recurrence of transitional cell carcinoma of the bladder. Bju International 97, 997\u20131001 (2006)","journal-title":"Bju International"},{"key":"1059_CR10","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1007\/s00345-018-2380-x","volume":"36","author":"F. Soria","year":"2018","unstructured":"F. Soria, M.J. Droller, Y. Lotan, P. Gontero, D. D\u2019Andrea, K.M. Gust, et al., An up-to-date catalog of available urinary biomarkers for the surveillance of non-muscle invasive bladder cancer. World J. Urol. 36, 1981\u20131995 (2018)","journal-title":"World J. Urol."},{"key":"1059_CR11","doi-asserted-by":"crossref","unstructured":"R. Chou, J.L. Gore, D. Buckley, R. Fu, K. Gustafson, J.C. Griffin, et al., Urinary Biomarkers for Diagnosis of Bladder Cancer: a systematic review and meta-analysis. Annl Internal Med. 163, 922\u2013931 (2015)","DOI":"10.7326\/M15-0997"},{"key":"1059_CR12","doi-asserted-by":"publisher","first-page":"2586","DOI":"10.1016\/j.gendis.2022.10.022","volume":"10","author":"J. Wang","year":"2023","unstructured":"J. Wang, J. Zhu, J. Hu, Z. Wang, X. Wang, J. Pan, et al., A novel in vitro prognostic model of bladder cancer based on urine-derived living tumor cells. Genes Dis 10, 2586\u20132596 (2023)","journal-title":"Genes Dis"},{"key":"1059_CR13","doi-asserted-by":"publisher","first-page":"7283","DOI":"10.1002\/cam4.5481","volume":"12","author":"F. Gao","year":"2023","unstructured":"F. Gao, J. Wang, Y. Yu, J. Yan, G. Ding, Comprehensive optimization of urinary exfoliated tumor cells tests in bladder cancer with a promising microfluidic platform. Cancer Med. 12, 7283\u20137293 (2023)","journal-title":"Cancer Med."},{"key":"1059_CR14","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.3389\/fonc.2020.01774","volume":"10","author":"S. Carvalho","year":"2020","unstructured":"S. Carvalho, C.M. Abreu, D. Ferreira, L. Lima, J.A. Ferreira, L.L. Santos, et al., Phenotypic analysis of urothelial exfoliated cells in bladder cancer via microfluidic immunoassays: sialyl-Tn as a novel biomarker in liquid biopsies. Front. Oncol 10, 1774 (2020)","journal-title":"Front. Oncol"},{"key":"1059_CR15","doi-asserted-by":"publisher","first-page":"4073","DOI":"10.1158\/0008-5472.CAN-17-2615","volume":"78","author":"A. Chen","year":"2018","unstructured":"A. Chen, G. Fu, Z. Xu, Y. Sun, X. Chen, K.S. Cheng, et al., Detection of urothelial bladder carcinoma via microfluidic immunoassay and single-cell DNA copy-number alteration analysis of captured urinary-exfoliated tumor cells. Cancer Res 78, 4073\u20134085 (2018)","journal-title":"Cancer Res"},{"key":"1059_CR16","doi-asserted-by":"crossref","unstructured":"W. Zhang, X. Duan, Z. Zhang, Z. Yang, C. Zhao, C. Liang, et al., Combination of CT and telomerase+ circulating tumor cells improves diagnosis of small pulmonary nodules. JCI Insight. 6(11), e148182 (2021)","DOI":"10.1172\/jci.insight.148182"},{"key":"1059_CR17","doi-asserted-by":"publisher","first-page":"101161","DOI":"10.1016\/j.eclinm.2021.101161","volume":"43","author":"Z. Yang","year":"2022","unstructured":"Z. Yang, H. Bai, L. Hu, D. Kong, G. Li, C. Zhao, et al., Improving the diagnosis of prostate cancer by telomerase-positive circulating tumor cells: a prospective pilot study. eClinicalMedicine 43, 101161 (2022)","journal-title":"eClinicalMedicine"},{"key":"1059_CR18","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1186\/s12916-021-02138-7","volume":"19","author":"W. Zhang","year":"2021","unstructured":"W. Zhang, T. Qin, Z. Yang, L. Yin, C. Zhao, L. Feng, et al., Telomerase-positive circulating tumor cells are associated with poor prognosis via a neutrophil-mediated inflammatory immune environment in glioma. BMC Med. 19, 277 (2021)","journal-title":"BMC Med."},{"key":"1059_CR19","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1016\/j.eururo.2007.09.036","volume":"52","author":"K. Bensalah","year":"2007","unstructured":"K. Bensalah, F. Montorsi, S.F. Shariat, Challenges of cancer biomarker profiling. Eur Urol 52, 1601\u20131609 (2007)","journal-title":"Eur Urol"},{"key":"1059_CR20","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/j.euo.2021.10.003","volume":"4","author":"E. Laukhtina","year":"2021","unstructured":"E. Laukhtina, et al., Diagnostic accuracy of novel urinary biomarker tests in non\u2013muscle-invasive bladder cancer: a systematic review and network meta-analysis. Eur Urol Oncol 4, 927\u2013942 (2021)","journal-title":"Eur Urol Oncol"},{"key":"1059_CR21","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s00345-022-04253-3","volume":"41","author":"Y. Soorojebally","year":"2023","unstructured":"Y. Soorojebally, Y. Neuzillet, M. Roumigui\u00e9, P.-J. Lamy, Y. Allory, F. Descotes, et al., Urinary biomarkers for bladder cancer diagnosis and NMIBC follow-up: a systematic review. World J. Urol. 41, 345\u2013359 (2023)","journal-title":"World J. Urol."},{"key":"1059_CR22","doi-asserted-by":"publisher","first-page":"104437","DOI":"10.1016\/j.ebiom.2023.104437","volume":"89","author":"P. Wang","year":"2023","unstructured":"P. Wang, Y. Shi, J. Zhang, J. Shou, M. Zhang, D. Zou, et al., UCseek: ultrasensitive early detection and recurrence monitoring of urothelial carcinoma by shallow-depth genome-wide bisulfite sequencing of urinary sediment DNA. eBioMedicine 89, 104437 (2023)","journal-title":"eBioMedicine"},{"key":"1059_CR23","doi-asserted-by":"publisher","first-page":"16284","DOI":"10.1021\/acs.analchem.0c04282","volume":"92","author":"Z. Wang","year":"2020","unstructured":"Z. Wang, J. Chen, L. Yang, M. Cao, Y. Yu, R. Zhang, et al., Single-cell sequencing-enabled hexokinase 2 assay for noninvasive bladder cancer diagnosis and screening by detecting rare malignant cells in urine. Anal. Chem. 92, 16284\u201316292 (2020)","journal-title":"Anal. Chem."},{"key":"1059_CR24","doi-asserted-by":"publisher","first-page":"5646","DOI":"10.1158\/1078-0432.CCR-20-0401","volume":"26","author":"S. Zeng","year":"2020","unstructured":"S. Zeng, Y. Ying, N. Xing, B. Wang, Z. Qian, Z. Zhou, et al., Noninvasive detection of urothelial carcinoma by cost-effective low-coverage whole-genome sequencing from urine-exfoliated cell DNA. Clin. Cancer. Res. 26, 5646\u20135654 (2020)","journal-title":"Clin. Cancer. Res."},{"key":"1059_CR25","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/s41585-022-00578-1","volume":"19","author":"J.Y.-C. Teoh","year":"2022","unstructured":"J.Y.-C. Teoh, A.M. Kamat, P.C. Black, P. Grivas, S.F. Shariat, M. Babjuk, Recurrence mechanisms of non-muscle-invasive bladder cancer\u2014a clinical perspective. Nat Rev Urol 19, 280\u2013294 (2022)","journal-title":"Nat Rev Urol"},{"key":"1059_CR26","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.eururo.2020.12.033","volume":"79","author":"R.J. Sylvester","year":"2021","unstructured":"R.J. Sylvester, et al., European Association of Urology (EAU) prognostic factor risk groups for non\u2013muscle-invasive bladder cancer (NMIBC) incorporating the WHO 2004\/2016 and WHO 1973 classification systems for grade: an update from the EAU NMIBC Guidelines Panel. Eur Urol 79, 480\u2013488 (2021)","journal-title":"Eur Urol"},{"key":"1059_CR27","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/j.eururo.2018.02.014","volume":"73","author":"M.G.K. Cumberbatch","year":"2018","unstructured":"M.G.K. Cumberbatch, B. Foerster, J.W.F. Catto, A.M. Kamat, W. Kassouf, I. Jubber, et al., Repeat transurethral resection in non\u2013muscle-invasive bladder cancer: a systematic review. Eur Urol 73, 925\u2013933 (2018)","journal-title":"Eur Urol"},{"key":"1059_CR28","doi-asserted-by":"crossref","unstructured":"R.T. Bryan, S.I. Collins, M.C. Daykin, M.P. Zeegers, K.K. Cheng, D.M.A. Wallace, et al., Mechanisms of recurrence of Ta\/T1 bladder cancer. Ann R Coll Surg Engl 92, 519\u2013524(2015)","DOI":"10.1308\/003588410X12664192076935"},{"key":"1059_CR29","first-page":"355","volume":"61","author":"R. Simon","year":"2001","unstructured":"R. Simon, E. Eltze, K.-L. Sch\u00e4fer, H. B\u00fcrger, A. Semjonow, L. Hertle, et al., Cytogenetic analysis of multifocal bladder cancer supports a monoclonal origin and intraepithelial spread of tumor cells1. Cancer Res 61, 355\u2013362 (2001)","journal-title":"Cancer Res"},{"issue":"11","key":"1059_CR30","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1056\/NEJM199203123261104","volume":"326","author":"D. Sidransky","year":"1992","unstructured":"D. Sidransky, P. Frost, A. Von Eschenbach, R. Oyasu, A.C. Preisinger, B. Vogelstein, Clonal origin of bladder cancer. N Engl J Med. 326, 737\u2013740 (1992)","journal-title":"N Engl J Med"},{"key":"1059_CR31","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1186\/s12885-015-1859-8","volume":"15","author":"\u00d6. Acar","year":"2015","unstructured":"\u00d6. Acar, E. \u00d6zkurt, G. Demir, H. Sara\u00e7, C. Alkan, T. Esen, et al., Determining the origin of synchronous multifocal bladder cancer by exome sequencing. BMC Cancer 15, 871 (2015)","journal-title":"BMC Cancer"},{"key":"1059_CR32","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.eururo.2021.08.010","volume":"81","author":"M. Babjuk","year":"2022","unstructured":"M. Babjuk, M. Burger, O. Capoun, D. Cohen, E.M. Comp\u00e9rat, J.L. Dominguez Escrig, et al., European Association of Urology Guidelines on non\u2013muscle-invasive bladder cancer (Ta, T1, and carcinoma in situ). Eur Urol 81, 75\u201394 (2022)","journal-title":"Eur Urol"},{"key":"1059_CR33","doi-asserted-by":"crossref","unstructured":"J.M. Holzbeierlein, B.R. Bixler, D.I. Buckley, S.S. Chang, R. Holmes, A.C. James, et al., Diagnosis and treatment of non-muscle invasive bladder cancer: AUA\/SUO guideline: 2024 amendment. J Urol. 211(4), 533\u2013538 (2024).","DOI":"10.1097\/JU.0000000000003846"},{"key":"1059_CR34","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.eururo.2017.06.038","volume":"73","author":"J. Bosschieter","year":"2018","unstructured":"J. Bosschieter, J.A. Nieuwenhuijzen, T. van Ginkel, A.N. Vis, B. Witte, D. Newling, et al., Value of an immediate intravesical instillation of mitomycin c in patients with non\u2013muscle-invasive bladder cancer: a prospective multicentre randomised study in 2243 patients. Eur Urol 73, 226\u2013232 (2018)","journal-title":"Eur Urol"},{"key":"1059_CR35","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.eururo.2013.06.009","volume":"64","author":"N. Perlis","year":"2013","unstructured":"N. Perlis, A.R. Zlotta, J. Beyene, A. Finelli, N.E. Fleshner, G.S. Kulkarni, Immediate post\u2013transurethral resection of bladder tumor intravesical chemotherapy prevents non\u2013muscle-invasive bladder cancer recurrences: an updated meta-analysis on 2548 patients and quality-of-evidence review. Eur Urol 64, 421\u2013430 (2013)","journal-title":"Eur Urol"},{"key":"1059_CR36","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.eururo.2015.05.050","volume":"69","author":"R.J. Sylvester","year":"2016","unstructured":"R.J. Sylvester, W. Oosterlinck, S. Holmang, M.R. Sydes, A. Birtle, S. Gudjonsson, et al., Systematic review and individual patient data meta-analysis of randomized trials comparing a single immediate instillation of chemotherapy after transurethral resection with transurethral resection alone in patients with stage pTa\u2013pT1 urothelial carcinoma of the bladder: which patients benefit from the instillation? Eur Urol 69, 231\u2013244 (2016)","journal-title":"Eur Urol"},{"key":"1059_CR37","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.purol.2021.01.011","volume":"31","author":"B. Gondran-Tellier","year":"2021","unstructured":"B. Gondran-Tellier, R. Abdallah, P.C. Sichez, A. Akiki, H. Toledano, S. Gaillet, et al., Continuous saline bladder irrigation after blue light transurethral resection of bladder tumor increases recurrence-free survival in low- to intermediate-risk non-muscle invasive bladder cancer. Prog Urol 31, 316\u2013323 (2021)","journal-title":"Prog Urol"},{"key":"1059_CR38","first-page":"E480","volume":"12","author":"J. Do","year":"2018","unstructured":"J. Do, S.W. Lee, S.U. Jeh, J.S. Hwa, J.S. Hyun, S.M. Choi, Overnight continuous saline irrigation after transurethral resection for non-muscle-invasive bladder cancer is helpful in prevention of early recurrence. Canad Urol Assoc J 12, E480 (2018)","journal-title":"Canad Urol Assoc J"},{"key":"1059_CR39","doi-asserted-by":"publisher","first-page":"638065","DOI":"10.3389\/fonc.2021.638065","volume":"11","author":"Y. Yang","year":"2021","unstructured":"Y. Yang, C. Liu, X. Yan, J. Li, X. Yang, Overnight continuous saline bladder irrigation after en bloc resection of bladder tumor does not improve oncological outcomes in patients who have received intravesical chemotherapy. Front. Oncol 11, 638065 (2021)","journal-title":"Front. Oncol"}],"container-title":["Cellular Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13402-025-01059-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13402-025-01059-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13402-025-01059-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T12:42:38Z","timestamp":1757162558000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13402-025-01059-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,29]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["1059"],"URL":"https:\/\/doi.org\/10.1007\/s13402-025-01059-4","relation":{},"ISSN":["2211-3428","2211-3436"],"issn-type":[{"value":"2211-3428","type":"print"},{"value":"2211-3436","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,29]]},"assertion":[{"value":"24 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study complied with all relevant ethical regulations and was approved by the Ethical Committee of National Cancer Center\/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College (No. NGC2022C-490). All patients provided oral and written informed consent for participation and publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}